SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: garden_man who wrote (1864)12/12/1996 5:52:00 PM
From: joe blow23   of 2281
 
Joe, thanks for the post. This has to be a history based article, still however says alot for the company's near future. Just getting on the list, will only increase the company's visibility.

On the results of the Barbados study, although the HIV levels only decreased by 21% lets keep two things in mind:

1) No other medication previously given, nor given in tandem with Reticulose, and
2) Those patients who were given the placebo increased their HIV levels by 33%.

That could argueably be considered a %50 impact overall.
Mel

Reticulose
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News